INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "RNAI CONSTRUCTS AND METHODS FOR INHIBITING CNR1 EXPRESSION"

GENEVA, Dec. 24 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2025/033638) for "RNAI CONSTRUCTS AND METHODS FOR INHIBITING CNR1 EXPRESSION" on Jun 13, 2025. With publication no. WO/2025/260042, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Bin (c/o Amgen Inc., One Amgen Center DriveLaw Department - Patent Operations M/S 28-5-AThousand Oaks, California 91320-1799), HOMANN, Oliver R. (c/o Amgen Inc., One Amgen Center DriveLaw Department - Patent Operations...